全球人工智慧（AI）诊断市场规模、份额、趋势和成长分析报告（2026-2034）

预计到 2034 年，诊断人工智慧市场规模将从 2025 年的 26.4 亿美元成长至 167.7 亿美元，2026 年至 2034 年的复合年增长率为 22.8%。

机器学习和医学影像技术的进步正推动全球诊断人工智慧市场快速扩张。人工智慧工具正被越来越多地用于分析放射影像、病理切片和患者数据，以实现疾病的早期检测。对数位医疗基础设施投资的增加以及人工智慧驱动的临床支援系统日益普及，正在加速市场成长。

关键成长要素包括熟练医疗专业人员短缺、诊断工作量增加以及对提高准确性和效率的需求。人工智慧演算法能够增强影像解读能力、减少诊断错误并支援快速临床决策。与电子健康记录和云端平台的整合将进一步加速医院和诊断中心采用人工智慧技术。

展望未来，监管核准和报销政策将在人工智慧技术的广泛应用过程中发挥关键作用。演算法透明度、检验和互通性的持续改进将增强临床医生的信心。随着医疗系统拥抱数据驱动型医疗，人工智慧在诊断领域的应用有望成为现代临床工作流程的核心要素。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球人工智慧（AI）诊断市场：按组件划分

• 市场分析、洞察与预测
• 软体
• 硬体
• 服务

第五章 全球人工智慧（AI）诊断市场：按诊断类型划分

• 市场分析、洞察与预测
• 心臟病学
• 肿瘤学
• 病理
• 放射科
• 胸部和肺部
• 神经病学
• 其他的

第六章 全球人工智慧（AI）诊断市场：按地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第七章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第八章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Siemens Healthineers
  • Zebra Technologies Corporation
  • Riverain Technologies
  • Vuno Inc
  • Aidoc
  • NovaSignal Corporation
  • Imagen
  • Digital Diagnostics Inc
  • GE Healthcare
  • AliveCor Inc
  • F. Hoffmann-La Roche Ltd

The Artificial Intelligence in Diagnostics Market size is expected to reach USD 16.77 Billion in 2034 from USD 2.64 Billion (2025) growing at a CAGR of 22.8% during 2026-2034.

The global artificial intelligence in diagnostics market is expanding rapidly due to advancements in machine learning and medical imaging technologies. AI-powered tools are increasingly used to analyze radiology images, pathology slides, and patient data for early disease detection. Growing investments in digital healthcare infrastructure and rising acceptance of AI-driven clinical support systems are accelerating market growth.

Major growth drivers include shortages of skilled healthcare professionals, increasing diagnostic workloads, and the need for improved accuracy and efficiency. AI algorithms enhance image interpretation, reduce diagnostic errors, and support faster clinical decision-making. Integration with electronic health records and cloud-based platforms further strengthens implementation across hospitals and diagnostic centers.

Looking forward, regulatory approvals and reimbursement policies will play a crucial role in broader adoption. Continued improvements in algorithm transparency, validation, and interoperability will increase clinician trust. As healthcare systems embrace data-driven medicine, AI in diagnostics is expected to become a core component of modern clinical workflows.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Component

• Software
• Hardware
• Services

By Diagnosis

• Cardiology
• Oncology
• Pathology
• Radiology
• Chest and Lung
• Neurology
• Others

COMPANIES PROFILED

• Siemens Healthineers, Zebra Technologies Corporation, Riverain Technologies, Vuno Inc, Aidoc, NovaSignal Corporation, Imagen, Digital Diagnostics Inc, GE Healthcare, AliveCor Inc, F HoffmannLa Roche Ltd
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL ARTIFICIAL INTELLIGENCE IN DIAGNOSTICS MARKET: BY COMPONENT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Component
• 4.2. Software Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Hardware Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ARTIFICIAL INTELLIGENCE IN DIAGNOSTICS MARKET: BY DIAGNOSIS 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Diagnosis
• 5.2. Cardiology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Pathology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Radiology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Chest and Lung Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Neurology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ARTIFICIAL INTELLIGENCE IN DIAGNOSTICS MARKET: BY REGION 2022-2034(USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Component
  • 6.2.2 By Diagnosis
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Component
  • 6.3.2 By Diagnosis
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Component
  • 6.4.2 By Diagnosis
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Component
  • 6.5.2 By Diagnosis
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 South East Asia
  • 6.5.8 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Component
  • 6.6.2 By Diagnosis
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL ARTIFICIAL INTELLIGENCE IN DIAGNOSTICS INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Siemens Healthineers
  • 8.2.2 Zebra Technologies Corporation
  • 8.2.3 Riverain Technologies
  • 8.2.4 Vuno Inc
  • 8.2.5 Aidoc
  • 8.2.6 NovaSignal Corporation
  • 8.2.7 Imagen
  • 8.2.8 Digital Diagnostics Inc
  • 8.2.9 GE Healthcare
  • 8.2.10 AliveCor Inc
  • 8.2.11 F. Hoffmann-La Roche Ltd